Processa pharmaceuticals announces first quarter 2022 financial results and provides corporate update

Hanover, md., may 12, 2022 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) ("processa" or the "company"), a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient's survival and/or quality of life, today announced financial results for the quarter ended march 31, 2022, and provided an update on its clinical programs.
PCSA Ratings Summary
PCSA Quant Ranking